作者单位:
Labfit-HPRD Health Products Research and Development, Lda, Edifício UBIMEDICAL Estrada Municipal 506, 6200-284 Covilhã, Portugal.
[1]
CICS-UBI-Health Sciences Research Center, University of Beira Interior, Av. Infante D. Henrique, 6200-358 Covilhã, Portugal.
[2]
Faculty of Health Sciences, University of Beira Interior, Av. Infante D. Henrique, 6200-358 Covilhã, Portugal.
[3]
Laboratórios Basi, Mortágua, Portugal, Parque Industrial Manuel Lourenço Ferreira, Lote 15, 3450-232 Mortágua, Portugal.
[4]
EPISKIN, EPISKIN 4, Rue Alexander Fleming, 69366 Lyon, France.
[5]
TOXRUN-Toxicology Research Unit, University Institute of Health Sciences (IUCS), Advanced Polytechnic and University Cooperative (CESPU), CRL, 4585-116 Gandra, Portugal.
[6]
Department of Public Health and Forensic Sciences, and Medical Education, Faculty of Medicine, University of Porto, 4099-002 Porto, Portugal.
[7]
UCIBIO-REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4099-002 Porto, Portugal.
[8]
MTG Research and Development Lab, Rua Professor Joaquim Bastos, 4200-604 Porto, Portugal.
[9]
DOI
10.3390/pharmaceutics14081554
PMID
35893811
发布时间
2022-07-31